Finvest
CNC Managed Care · Medicaid · ACA Marketplace · Government health · Thesis updated June 12, 2026

Recovery depends on Marketplace risk math

01 Running thesis

A recovery, but not a free pass

Centene is trying to prove that 2025 was a bad pricing year, not a broken business. Q1 helped. Management raised full-year 2026 adjusted EPS guidance to greater than $3.40, up from greater than $3, and Medicaid cost control looked better than expected.

The bull case now rests on two ideas. First, Medicaid medical costs keep improving as state rates and care programs catch up. Second, the Marketplace business can make money even with a sicker member base, because ACA risk adjustment is meant to pay plans that cover higher-risk people.

The bear case is narrower but still serious. Centene is counting on a meaningful Marketplace risk adjustment offset. If Wakely risk data or later claims data show the offset is too small or too late, Ambetter margins could fall short of the older 4% pretax target.

This is a middle-score setup. The company has scale, better Q1 results, and a clearer recovery path. But growth is not clean, the balance sheet is not light, and the key Marketplace math is still being tested.

Apr 2026Centene raised full-year 2026 adjusted EPS guidance to greater than $3.40 after Q1. Management also said the Marketplace strategy is working, though it kept the embedded Marketplace margin assumption near 3% while waiting for more risk data.
Apr 2026The Q1 2026 Form 10-Q showed Marketplace membership of 3,582,200 and a 50 basis point improvement in Medicaid HBR. It also showed no stock repurchases under the buyback program during the quarter.
Feb 2026The 2025 Form 10-K confirmed the 2026 setup already given on the Q4 call. Marketplace repricing and Medicaid redetermination risk remained the key items.
Feb 2026Management gave 2026 adjusted EPS guidance of greater than $3 and framed the year as a margin recovery. Marketplace was expected to become smaller but more profitable after rate refiling.
Oct 2025Management said 2026 Marketplace rate increases averaged in the mid-30s, but also warned the market could contract in a high-teens to mid-30s range. The recovery case became clearer, while membership risk stayed high.
Oct 2025The Q3 2025 Form 10-Q included a $6.7 billion non-cash goodwill impairment and showed high medical cost pressure. It also confirmed corrective Marketplace pricing actions covering about 95% of membership.
Jul 2025Centene cut 2025 adjusted EPS guidance to about $1.75 after a major Marketplace pricing miss and higher Medicaid costs. The investment case shifted from near-term earnings to a 2026 recovery.
Jul 2025The Q2 2025 Form 10-Q added major regulatory risk from OBBBA and Marketplace rule changes. It also showed that Marketplace morbidity and Medicaid cost pressure were worse than expected.
02 Business model

Paid per member, hurt by claims

Centene is a managed care organization. Governments and members pay it premiums, often on a per-member-per-month basis. Centene then pays doctors, hospitals, pharmacies, and other providers for care.

The business works when premiums are set higher than medical costs and overhead. A key metric is the health benefits ratio, or HBR, which means medical costs as a percent of premium revenue. Lower is usually better, as long as care quality holds up.

Centene’s edge comes from scale in Medicaid, long ties with state governments, and experience serving lower-income and complex-needs members. That also creates risk. States set many rates, rules can change, and sick members can quickly raise claims costs.

Technology and tighter operations can help. Management has pointed to data, clinical programs, network design, and fraud, waste, and abuse work as tools to lower cost. Still, pricing and regulation matter more here than brand power.

03 Product portfolio

Four big health-plan engines

Cash cow

Medicaid

This is Centene’s largest business line. It serves low-income families and higher-need members, and the main test is whether state rates keep up with medical cost trend.

Growth engine

Ambetter Marketplace

Ambetter sells ACA plans to individuals. It is the main recovery lever, but 2026 profitability depends on risk adjustment for a sicker member mix.

Option

Medicare Advantage

Centene is managing this business for profit, not just size. Management is aiming for Medicare Advantage breakeven by 2027.

Growth engine

Medicare Part D

Part D covers prescription drugs for seniors. Revenue is growing because Inflation Reduction Act changes shifted more cost and premium responsibility into the plans.

Option

Dual-eligible plans

These serve people who qualify for both Medicare and Medicaid. Centene may benefit over time because future CMS rules push more integrated care through D-SNP plans.

Steady

Other services

This bucket includes pharmacy operations, vision and dental, clinical care, behavioral health, and corporate services. Centene signed a deal in 2025 to divest the remaining Magellan Health businesses.

04 Business segments

Medicaid still sets the tone

Medicaid58%modest
Medicare21%growing fast
Commercial19%declining
Other2%declining

Mix is based on Q1 2026 total external revenues from the Form 10-Q. Medicaid is the largest segment, so state rates and medical cost trend have an outsized effect on the company.

05 Risk factors

What could break the recovery

Marketplace risk adjustment shortfall

High impact · Medium odds

Centene has kept a higher-acuity Silver population in Marketplace. That can be profitable if risk adjustment pays enough, but the offset is still an estimate. Management has embedded about a 3% Marketplace pretax margin for now, below the earlier roughly 4% target.

We watchJune Wakely risk data, Q2 2026 Marketplace HBR, and any change in the expected risk adjustment receivable.

Medicaid cost trend outruns rates

High impact · Medium odds

Medicaid is Centene’s biggest business. The company is seeing cost pressure from care use, behavioral health, home and community-based services, and high-cost drugs. If state rate increases lag the new cost level, margins can slip even if membership is stable.

We watchMedicaid HBR versus the prior-year 93.7% target line, composite rate yield, and state rate updates.

Regulation cuts members and worsens mix

High impact · High odds

The OBBBA, the Marketplace Integrity and Affordability Final Rule, and the end of enhanced APTCs have already reduced Marketplace membership and are expected to raise Marketplace morbidity. Medicaid work requirements and more frequent eligibility checks could also reduce Medicaid Expansion membership and leave a sicker pool behind.

We watchMarketplace membership, Medicaid redetermination losses, state implementation plans for OBBBA, and litigation around the Final Rule.

Medicare execution stays uneven

Medium impact · Medium odds

Medicare Advantage is still on a path toward breakeven by 2027, not already fixed. Part D is growing, but IRA changes also changed cash flows and risk sharing. A delay in CMS payments tied to Part D receivables could pressure cash flow.

We watchMedicare Advantage margin progress, PDP specialty drug trend, CMS receivable collections, and Star Ratings.

Debt limits capital returns

Medium impact · Medium odds

Centene made no open-market stock repurchases in Q1 2026 and used cash to reduce debt. Long-term debt was $16.3 billion at March 31, 2026. Buybacks could stay paused if management favors debt paydown or regulated-capital needs.

We watchDebt-to-capital ratio, debt repurchase activity, unrestricted cash, and any signal that the share repurchase program restarts.
06 Quick answers

In one breath

How does Centene make money?

Centene collects premiums for health-plan members, often from state and federal programs. It makes money when medical claims and operating costs come in below those premiums.

Why is Marketplace risk adjustment so important for Centene?

Risk adjustment moves money toward plans that cover sicker ACA members. Centene’s 2026 Marketplace thesis depends on getting paid enough for a higher-acuity Silver population.

Is Medicaid good or bad for Centene?

Medicaid is Centene’s core strength and its biggest exposure. Scale helps, but profits depend on states setting rates that match the real cost of care.

Why did Centene raise 2026 guidance?

Management raised adjusted EPS guidance after strong Q1 results. The raise reflected better operating performance, confidence in Medicaid cost control, and a Marketplace strategy that management says is working so far.